"breast cancer survival" trang 9 - tải miễn phí từ tailieunhanh
Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival

Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival
12    4    1
Results of treatment for paget’s disease of the breast at the national cancer hospital in Vietnam

Results of treatment for paget’s disease of the breast at the national cancer hospital in Vietnam
9    12    1
AKAP3 correlates with triple negative status and disease free survival in breast cancer

AKAP3 correlates with triple negative status and disease free survival in breast cancer
7    23    1
Impact of pectoralis muscle loss on cardiac outcome and survival in Cancer patients who received anthracycline based chemotherapy: Retrospective study

Impact of pectoralis muscle loss on cardiac outcome and survival in Cancer patients who received anthracycline based chemotherapy: Retrospective study
8    24    1
The prognostic association of SPAG5 gene expression in breast cancer patients with systematic therapy

The prognostic association of SPAG5 gene expression in breast cancer patients with systematic therapy
12    64    0
Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2- negative metastatic breast cancer: A network meta-analysis

Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2- negative metastatic breast cancer: A network meta-analysis
17    79    0
Trastuzumab use in older patients with HER2-positive metastatic breast cancer: Outcomes and treatment patterns in a whole-of-population Australian cohort (2003–2015)

Trastuzumab use in older patients with HER2-positive metastatic breast cancer: Outcomes and treatment patterns in a whole-of-population Australian cohort (2003–2015)
10    60    0
Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: The randomized controlled SENOMAC trial

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: The randomized controlled SENOMAC trial
7    95    1
Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes

Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes
9    33    1
Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: Result of an institution database from South Korea

Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: Result of an institution database from South Korea
8    46    1
Cost-effectiveness of bevacizumab plus paclitaxel versus paclitaxel for the first-line treatment of HER2-negative metastatic breast cancer in specialist oncology centers in France

Cost-effectiveness of bevacizumab plus paclitaxel versus paclitaxel for the first-line treatment of HER2-negative metastatic breast cancer in specialist oncology centers in France
11    76    1
Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: A retrospective cohort analysis

Locally advanced breast cancer treated with neoadjuvant chemotherapy and adjuvant radiotherapy: A retrospective cohort analysis
11    30    1
Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancer

Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancer
11    43    1
Prognosis of pregnancy-associated breast cancer: A meta-analysis

Prognosis of pregnancy-associated breast cancer: A meta-analysis
15    51    1
Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : A systematic review and meta-analysis

Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : A systematic review and meta-analysis
8    66    1
Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy

Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy
8    63    1
The treatment patterns, efficacy, and safety of nab® -paclitaxel for the treatment of metastatic breast cancer in the United States: Results from health insurance claims analysis

The treatment patterns, efficacy, and safety of nab® -paclitaxel for the treatment of metastatic breast cancer in the United States: Results from health insurance claims analysis
11    79    1
Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triplenegative breast cancer: A retrospective study on 129 cases

Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triplenegative breast cancer: A retrospective study on 129 cases
11    37    1
Metaplastic breast cancer: A comparison between the most common histologies with poor immunohistochemistry factors

Metaplastic breast cancer: A comparison between the most common histologies with poor immunohistochemistry factors
9    53    1
Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: A systematic review

Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: A systematic review
9    54    1